Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

Clinical trial NCT06099093 · RECRUITING

Trial details

NCT number: NCT06099093
Sponsor: Brigham and Women's Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-resistant Prostate Cancer Metastatic Castration-resistant Prostate Carcinoma

Start date: 2024-04-01
Primary completion: 2026-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.